HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00068991 |
Recruitment Status
:
Withdrawn
First Posted
: September 16, 2003
Last Update Posted
: June 1, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Infections | Behavioral: HIV skills training program and questionnaire Behavioral: Community-level stigma reduction program Behavioral: Cross-sectional survey | Phase 1 |
A previous study found that HIV-infected villagers in Anhui Province, China describe their quality of life as poor. While poverty, poor health, stigma, and discrimination contribute to this poor quality of life, all these issues are interrelated and deserve further investigation. The quality of life for HIV-infected people may be made better through education, either for HIV-infected people to learn more about HIV, the treatments they are receiving, and how to deal with their disease, or for HIV uninfected people to understand HIV infection and to reduce stigma and discrimination associated with HIV infection. This study will provide skills training to HIV-infected adults and anti-stigma and anti-discrimination training to influential community members. The purpose of this study is to evaluate the changes in quality of life in HIV-infected villagers living in Anhui Province, China that result after these two training programs are administered.
There will be 3 groups in this study. Group 1 participants will be HIV-infected villagers. Group 1 participants will take part in 2-hour skills training sessions every week from study entry to Week 8. Participants will also be asked to bring a family member to each training session. After completing training, participants will be asked to complete a post-training evaluation of the training sessions. Group 1 participants will be asked to complete questionnaires at study entry and 6 and 12 months after completion of training.
Group 2 participants will be villagers considered influential members of their community. In the first 2 months of the study, Group 2 participants will take part in four, 2-hour training sessions focusing on anti-stigma and anti-discrimination messages. Group 2 participants will also attend additional support meetings monthly, from Months 2 to 15. Group 2 participants will be evaluated before and after their training sessions to determine the improvements in knowledge and attitudes about HIV among group participants.
Group 3 participants will be randomly selected community members and will complete a cross-sectional survey at study entry and 6 and 12 months after Group 2's completion of training, to determine changing community attitudes about HIV as a result of Group 2's training. There will be no additional study visits or training for Group 3 participants.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Official Title: | A Cluster-Randomized Trial to Evaluate the Efficacy of a Combined Individual- and Community-Based Behavioral Intervention to Improve Quality of Life for HIV-Positive Villagers in Rural China (China CIPRA Project 2) |
Study Completion Date : | June 2007 |

Arm | Intervention/treatment |
---|---|
Experimental: 1
Participants will be HIV-infected villagers and will will take part in 2-hour skills training sessions every week from study entry to Week 8. Participants will bring a family member to each training session. After training, participants complete a post-training evaluation of the training sessions. Participants will also complete questionnaires at study entry and 6 and 12 months after completion of training.
|
Behavioral: HIV skills training program and questionnaire
Two-hour weekly skills training sessions followed by evaluation questionnaire
|
Experimental: 2
Participants will be villagers considered influential members of their community. In the first 2 months of the study, Participants will take part in four 2-hour training sessions focusing on anti-stigma and anti-discrimination messages. Participants will also attend additional support meetings monthly, from Months 2 to 15. They will be evaluated before and after their training sessions to determine the improvements in knowledge and attitudes about HIV among group participants.
|
Behavioral: Community-level stigma reduction program
Two-hour training sessions focusing on anti-stigma and anti-discrimination
|
Experimental: 3
Participants will be randomly selected community members and will complete a cross-sectional survey at study entry and 6 and 12 months after Group 2's completion of training to determine changing community attitudes about HIV as a result of Group 2's training. There will be no additional study visits or training for Group 3 participants.
|
Behavioral: Cross-sectional survey
Survey evaluation of community attitudes towards HIV
|
- Medical Outcomes Study HIV Health Survey (MOS-HIV) score in-HIV infected participants [ Time Frame: Throughout study ]
- Level of stigma among community members, as determined by HIV knowledge score and HIV attitudes and stigmatizing behaviors reported [ Time Frame: Throughout study ]
- Emotional well-being of HIV-infected participants, as determined by perceived support scale and stigma scale scores [ Time Frame: Throughout study ]
- Self-efficacy score in HIV-infected participants [ Time Frame: Throughout study ]
- Knowledge of correct condom use score among HIV-infected participants [ Time Frame: Throughout study ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria for All Participants:
- Live in one of the fourteen administrative villages in Funan County or Yingzhou District, Anhui Province, China
Inclusion Criteria for Group 1:
- HIV-infected
- Willing and able to take part in all study visits
- Willing and able to provide contact information for locator purposes
- Willing and able to bring a family member to training sessions
Inclusion Criteria for Group 2:
- Considered an influential member of their community
- Willing and able to take part in all training and follow-up support meetings
Inclusion Criteria for Group 3:
- Willing to complete the cross-sectional survey
Exclusion Criteria for All Study Participants:
- Spent more than 6 months outside of the community in the year prior to study entry
- Permanent disability (e.g., deafness, serious mental illness, mental retardation) that would interfere with the study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00068991
China | |
Chinese Center for Disease Control and Prevention | |
Beijing, China, 100050 |
Principal Investigator: | Zunyou Wu, MD, PhD | Centers for Disease Control and Prevention, China | |
Principal Investigator: | Jie Xu, MD, MS | Centers for Disease Control and Prevention, China |
Responsible Party: | Rona Siskind, DAIDS |
ClinicalTrials.gov Identifier: | NCT00068991 History of Changes |
Other Study ID Numbers: |
CIPRA Project 2 1U19AI051915-01 ( U.S. NIH Grant/Contract ) CIPRA CH 002 |
First Posted: | September 16, 2003 Key Record Dates |
Last Update Posted: | June 1, 2015 |
Last Verified: | September 2008 |
Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID):
Behavioral Intervention Study Randomized Prevention Trial China Condom Use |
STDs Sexual Partners HIV Seronegativity |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |